Pharmacokinetic Evaluation of Rifabutin in Combination with Lopinavir‐Ritonavir in Patients with HIV Infection and Active Tuberculosis

2009102 citationsJournal Articlebronze Open Access

Authors

Catherine Boulanger · University of Miami

Elena S. Hollender · State Hospital

Karen Farrell · State Hospital

Jerry Jean Stambaugh · State Hospital

Diane Maasen · Jackson Memorial Hospital

David Ashkin · State Hospital

Stephen Symes ·

Abstract

The recommended rifabutin doses for use with lopinavir-ritonavir may be inadequate in many patients. Monitoring of plasma concentrations is recommended.

Topics & Keywords

Tuberculosis Research and Epidemiology Pneumocystis jirovecii pneumonia detection and treatment HIV/AIDS drug development and treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Clinical Infectious Diseases

Volume 49, Issue 9, pp. 1305-1311

DOI: 10.1086/606056

Field-Weighted Citation Impact: 5.59